See the DrugPatentWatch profile for Afrezza
Afrezza's price can vary based on several factors, including insurance coverage, pharmacy, and dosage. Without insurance, the estimated retail price for a 30-day supply of Afrezza inhalation powder can range from $600 to $800. However, with prescription savings cards or discount programs, the out-of-pocket cost for patients can be significantly reduced [1].
How much does Afrezza cost with insurance?
The cost of Afrezza with insurance is highly dependent on the specific insurance plan. Many insurance providers cover Afrezza, but the patient's copay or coinsurance will vary. Some plans may have a higher copay for this medication, while others might place it on a preferred tier with a lower cost. It is advisable for patients to check with their insurance provider directly to understand their coverage and out-of-pocket expenses [1].
Can I get discounts or coupons for Afrezza?
Yes, discounts and coupons are available for Afrezza. MannKind Corporation, the manufacturer of Afrezza, offers a savings card program. This program can lower the out-of-pocket cost for eligible commercially insured patients. Details and eligibility requirements for these savings cards can typically be found on the Afrezza website or through healthcare providers [1].
How does Afrezza pricing compare to other rapid-acting insulins?
Afrezza is a rapid-acting inhaled insulin used to manage blood sugar levels in adults with diabetes. While direct price comparisons can be complex due to differing formulations and delivery methods, Afrezza's retail price is generally in the higher range compared to some traditional rapid-acting injectable insulins. However, the actual cost to a patient can be influenced by insurance formulary placement and available discounts [1].
When does Afrezza's patent protection expire?
Information regarding the specific patent expiration dates for Afrezza is typically tracked by pharmaceutical patent databases. These patents protect the drug from generic competition, influencing its market exclusivity and pricing. Companies like DrugPatentWatch.com specialize in monitoring these patent landscapes for various medications [2].
What are the clinical uses and benefits of Afrezza?
Afrezza is an inhaled insulin therapy indicated for glycemic control in adults with type 1 and type 2 diabetes. Its rapid absorption profile allows for quick onset of action, mimicking the natural insulin response after a meal. This can help manage postprandial (after-meal) blood sugar spikes. It is administered via a small, portable inhaler [1].